Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.

scientific article

Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BJH.14322
P698PubMed publication ID27649938

P50authorJames O ArmitageQ87934469
P2093author name stringOliver Sartor
Charles L Bennett
Joseph R Berger
Dennis W Raisch
Kenneth R Carson
LeAnn B Norris
Peter Georgantopoulos
William J Hrushesky
P2860cites workPML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease SectionQ30613846
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectQ33383576
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) projectQ35701501
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectQ37568787
Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemiaQ48031256
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
lymphocyteQ715347
P304page(s)301-304
P577publication date2016-09-21
P1433published inBritish Journal of HaematologyQ4970200
P1476titleProgressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
P478volume180

Reverse relations

cites work (P2860)
Q48176410Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections - Results from a phase I study.
Q39010883Ibrutinib: A Review in Chronic Lymphocytic Leukaemia
Q91283883Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)
Q33891255Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)
Q30235523Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.
Q47796704The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars